Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Skin and mucosal issues can occur after COVID-19 in adults and children.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

A woman's hair loss improved with treatment after a COVID-19 infection.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Finasteride may help reduce COVID-19 infection by altering a key gene.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Higher androgen levels might make COVID-19 worse, especially in men.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may cause temporary hair loss in some people.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.